STOCK TITAN

Evolent Health Inc - EVH STOCK NEWS

Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.

Evolent Health, Inc. (NYSE: EVH) plays a pivotal role in the healthcare sector by supporting health systems and physician organizations in their transition to value-based care and population health management. Headquartered in Arlington, Virginia, Evolent is backed by major entities such as The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth. The company’s core business revolves around providing integrated specialty care management services, total cost of care management, and health plan administration through an all-inclusive platform.

Evolent specializes in managing complex conditions in fields such as oncology, cardiology, and musculoskeletal markets, aiming to simplify healthcare and make it more affordable. The company's recent achievements include exceeding profitability expectations in the third quarter of 2023, adding new operating partnerships, and enhancing its financial outlook for the year. Evolent reported robust financial health with $184.5 million in cash and cash equivalents as of September 30, 2023.

The company’s culture is centered around collaboration, innovation, and a supportive work environment. Benefits like treadmill desks, healthy snacks, and wellness challenges underscore its commitment to employee well-being.

Notably, Evolent is also venturing into AI-driven healthcare solutions, as evidenced by its recent agreement to acquire Machinify Auth, a software platform that enhances clinical quality through advanced AI. This acquisition is expected to significantly improve the speed and efficiency of clinical reviews for various conditions.

In summary, Evolent Health continues to be a significant player in the healthcare industry, driving better health outcomes and financial performance through innovative solutions.

Rhea-AI Summary
Evolent Health's ACO saved Medicare over $55 million in 2022, ranking in the top 2% of ACOs. The ACO improved quality and reduced costs by 5.6%. Evolent's Performance Suite partnership with Humana in North Florida to launch on September 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.39%
Tags
conferences
-
Rhea-AI Summary
Evolent Health, Inc. announces Q2 2023 financial results with revenue of $469.1 million, an increase of 46.6% compared to the same period last year. Net loss margin was (8.8%) and Adjusted EBITDA margin was 10.1%. Total Lives on Platform increased to 78.6 million. The company signed new operating partnerships and expansions, showing strong business momentum. CEO Seth Blackley raises Adjusted EBITDA range for 2023 and expresses confidence in the company's medium-term target of $300 million in Adjusted EBITDA run-rate exiting 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
Rhea-AI Summary
Evolent Health Inc. (NYSE: EVH) appoints Toyin Ajayi, M.D., as the ninth independent board member, bringing expertise as a CEO, physician, and advocate for improving health care quality and cost for underserved populations. Dr. Ajayi's background in leading health care companies focused on Medicaid and dually eligible populations aligns with Evolent's mission of delivering value-based specialty care solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.5%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.73%
Tags
-
Rhea-AI Summary
Evolent Health, a health care company, is rebranding as Evolent and integrating its portfolio of solutions and businesses under that name. The company aims to improve health outcomes by working across specialties, providers, and settings. The rebranding includes a new tagline and corporate logo.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.65%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
none
-
Rhea-AI Summary

Evolent Health has nominated Richard Jelinek for election to its Board of Directors at the upcoming annual meeting scheduled for June 8, 2023. Jelinek, who is a managing partner at Czech One Capital Partners, has extensive experience in the health care sector, including executive roles at Aetna and CVS Health. His appointment coincides with the departure of current board member David Farner and former Chairman Frank Williams, both set to leave the board in June 2023. Evolent's leadership believes Jelinek's expertise will enhance the board's perspectives and support the company’s mission in value-based specialty care. The board expressed gratitude for the contributions of Farner and Williams, emphasizing the importance of evolving governance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
management
Rhea-AI Summary
Evolent Health, Inc. will release its Q1 2023 financial results on May 3, 2023, with a conference call to follow. The company will also host an Investor Day on May 23, 2023, featuring presentations on its long-term corporate strategy and financial outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags

FAQ

What is the current stock price of Evolent Health (EVH)?

The current stock price of Evolent Health (EVH) is $8.99 as of February 28, 2025.

What is the market cap of Evolent Health (EVH)?

The market cap of Evolent Health (EVH) is approximately 1.0B.

What is the primary business of Evolent Health, Inc.?

Evolent Health, Inc. supports health systems and physician organizations in transitioning to value-based care and population health management.

Where is Evolent Health headquartered?

Evolent Health is headquartered in Arlington, Virginia.

What recent financial achievements has Evolent Health reported?

Evolent Health exceeded profitability expectations in Q3 2023 and reported $184.5 million in cash and cash equivalents as of September 30, 2023.

What are some of the core services provided by Evolent Health?

Evolent Health provides specialty care management, total cost of care management, and health plan administration services.

What recent acquisition did Evolent Health announce?

Evolent Health announced the acquisition of Machinify Auth, an AI-powered software platform for clinical reviews.

Who are some of the backers of Evolent Health?

Evolent Health is backed by The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth.

What are the primary specialty care areas Evolent focuses on?

Evolent focuses on oncology, cardiology, and musculoskeletal care.

How does Evolent Health view its company culture?

Evolent Health promotes a collaborative and innovative work environment with benefits like treadmill desks and wellness challenges.

What is the significance of Evolent’s acquisition of Machinify Auth?

The acquisition is expected to enhance Evolent’s capabilities in AI-driven healthcare, improving the efficiency of clinical reviews.

How has Evolent Health performed financially in recent quarters?

Evolent Health has reported strong financial performance, with increased profitability, new partnerships, and a solid financial outlook for the year.
Evolent Health Inc

NYSE:EVH

EVH Rankings

EVH Stock Data

1.01B
113.93M
2.07%
113.87%
9.82%
Health Information Services
Services-management Services
Link
United States
ARLINGTON